EDESA BIOTECH

Serial Number 97414566
688

Registration Progress

Application Filed
May 17, 2022
Under Examination
Nov 26, 2024
Approved for Publication
Oct 15, 2024
Published for Opposition
Oct 15, 2024
Registered

Trademark Image

EDESA BIOTECH

Basic Information

Serial Number
97414566
Filing Date
May 17, 2022
Published for Opposition
October 15, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Nov 26, 2024
Application
Pending
Classes
005

Rights Holder

Edesa Biotech, Inc.

03
Address
100 Spy Court
Markham, Ontario L3R5H6
CA

Ownership History

Edesa Biotech, Inc.

Original Applicant
03
Markham, Ontario CA

Edesa Biotech, Inc.

Owner at Publication
03
Markham, Ontario CA

Legal Representation

Attorney
James M. Urzedowski

USPTO Deadlines

All Deadlines Cleared

All 8 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

29 events
Date Code Type Description Documents
Dec 9, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Nov 26, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 15, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 15, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 25, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 16, 2024 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Feb 12, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 8, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 8, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 8, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 8, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 8, 2024 GNRT O NON-FINAL ACTION E-MAILED Loading...
Feb 8, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 12, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 12, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 12, 2024 ALIE A ASSIGNED TO LIE Loading...
Aug 21, 2023 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Jun 20, 2023 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jun 20, 2023 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Jun 20, 2023 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jun 5, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 5, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 5, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 7, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 7, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 7, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 6, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
May 24, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 20, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of inflammation, immune-related diseases, gastroenterological illnesses, dermatological conditions and respiratory illnesses

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
BIOTECH